SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000930413-24-000914
Filing Date
2024-03-11
Accepted
2024-03-11 12:24:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 c108459_sc13ga.htm SC 13G/A 69058
  Complete submission text file 0000930413-24-000914.txt   70880
Mailing Address 730 THIRD AVENUE NEW YORK NY 10017-3206
Business Address 730 THIRD AVENUE NEW YORK NY 10017-3206 2129166042
TIAA CREF INVESTMENT MANAGEMENT LLC (Filed by) CIK: 0000887793 (see all company filings)

IRS No.: 133586142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Subject) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82025 | Film No.: 24737206
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)